LivaNova(LIVN) - 2025 Q3 - Quarterly Results

EXHIBIT 99.1 NEWS RELEASE LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance LONDON, NOV. 5, 2025 — LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the third quarter ended September 30, 2025 and raised full-year 2025 guidance. Financial Summary and Highlights (1) "LivaNova delivered another quarter of double-digit revenue growth, underscoring the durability of our Cardiopulmonary and Epilepsy businesses as a strong foundation for the Compan ...